Literature DB >> 25784554

A Residue Quartet in the Extracellular Domain of the Prolactin Receptor Selectively Controls Mitogen-activated Protein Kinase Signaling.

Chi Zhang1, Mads Nygaard2, Gitte W Haxholm2, Florence Boutillon1, Marie Bernadet1, Sylviane Hoos3, Patrick England3, Isabelle Broutin4, Birthe B Kragelund2, Vincent Goffin5.   

Abstract

Cytokine receptors elicit several signaling pathways, but it is poorly understood how they select and discriminate between them. We have scrutinized the prolactin receptor as an archetype model of homodimeric cytokine receptors to address the role of the extracellular membrane proximal domain in signal transfer and pathway selection. Structure-guided manipulation of residues involved in the receptor dimerization interface identified one residue (position 170) that in cell-based assays profoundly altered pathway selectivity and species-specific bio-characteristics. Subsequent in vitro spectroscopic and nuclear magnetic resonance analyses revealed that this residue was part of a residue quartet responsible for specific local structural changes underlying these effects. This included alteration of a novel aromatic T-stack within the membrane proximal domain, which promoted selective signaling affecting primarily the MAPK (ERK1/2) pathway. Importantly, activation of the MAPK pathway correlated with in vitro stabilities of ternary ligand·receptor complexes, suggesting a threshold mean lifetime of the complex necessary to achieve maximal activation. No such dependence was observed for STAT5 signaling. Thus, this study establishes a residue quartet in the extracellular membrane proximal domain of homodimeric cytokine receptors as a key regulator of intracellular signaling discrimination.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Cell Proliferation; Cell Surface Receptor; Cytokine; Extracellular Signal-regulated Kinase (ERK); Nuclear Magnetic Resonance (NMR); STAT Transcription Factor

Mesh:

Substances:

Year:  2015        PMID: 25784554      PMCID: PMC4424329          DOI: 10.1074/jbc.M115.639096

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Model for growth hormone receptor activation based on subunit rotation within a receptor dimer.

Authors:  Richard J Brown; Julian J Adams; Rebecca A Pelekanos; Yu Wan; William J McKinstry; Kathryn Palethorpe; Ruth M Seeber; Thea A Monks; Karin A Eidne; Michael W Parker; Michael J Waters
Journal:  Nat Struct Mol Biol       Date:  2005-08-21       Impact factor: 15.369

2.  Episodic evolution of prolactin receptor gene in mammals: coevolution with its ligand.

Authors:  Ying Li; Michael Wallis; Ya-ping Zhang
Journal:  J Mol Endocrinol       Date:  2005-12       Impact factor: 5.098

3.  Growth hormone binding affinity for its receptor surpasses the requirements for cellular activity.

Authors:  K H Pearce; B C Cunningham; G Fuh; T Teeri; J A Wells
Journal:  Biochemistry       Date:  1999-01-05       Impact factor: 3.162

Review 4.  Who climbs the tryptophan ladder? On the structure and function of the WSXWS motif in cytokine receptors and thrombospondin repeats.

Authors:  Johan G Olsen; Birthe B Kragelund
Journal:  Cytokine Growth Factor Rev       Date:  2014-05-09       Impact factor: 7.638

5.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

6.  Mutations of ovine and bovine placental lactogens change, in different ways, the biological activity mediated through homologous and heterologous lactogenic receptors.

Authors:  D Helman; A Herman; J Paly; O Livnah; P A Elkins; A M de Vos; J Djiane; A Gertler
Journal:  J Endocrinol       Date:  2001-04       Impact factor: 4.286

7.  Characterization of two constitutively active prolactin receptor variants in a cohort of 95 women with multiple breast fibroadenomas.

Authors:  Carine Courtillot; Zeina Chakhtoura; Roman Bogorad; Catherine Genestie; Sophie Bernichtein; Yasmina Badachi; Gilbert Janaud; Jean-Pierre Akakpo; Anne Bachelot; Frédérique Kuttenn; Vincent Goffin; Philippe Touraine
Journal:  J Clin Endocrinol Metab       Date:  2009-11-06       Impact factor: 5.958

8.  Structural and thermodynamic bases for the design of pure prolactin receptor antagonists: X-ray structure of Del1-9-G129R-hPRL.

Authors:  Jean-Baptiste Jomain; Estelle Tallet; Isabelle Broutin; Sylviane Hoos; Jan van Agthoven; Arnaud Ducruix; Paul A Kelly; Birthe B Kragelund; Patrick England; Vincent Goffin
Journal:  J Biol Chem       Date:  2007-09-04       Impact factor: 5.157

9.  A potent erythropoietin-mimicking human antibody interacts through a novel binding site.

Authors:  Zhihong Liu; Vincent S Stoll; Peter J Devries; Clarissa G Jakob; Nancy Xie; Robert L Simmer; Susan E Lacy; David A Egan; John E Harlan; Richard R Lesniewski; Edward B Reilly
Journal:  Blood       Date:  2007-07-09       Impact factor: 22.113

10.  A single phosphotyrosine residue of the prolactin receptor is responsible for activation of gene transcription.

Authors:  J J Lebrun; S Ali; V Goffin; A Ullrich; P A Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.